日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial

一项针对丹麦近视儿童的安慰剂对照随机临床试验，评估了0.01%和0.1%负荷剂量阿托品治疗（包括洗脱期）的3年疗效。

期刊:British Journal of Ophthalmology
影响因子:3.5
doi:10.1136/bjo-2024-326918
Hansen, Niklas; Hvid-Hansen, Anders; Møller, Flemming; Bek, Toke; Larsen, Dorte; Jacobsen, Nina; Kessel, Line
发表日期：2025
文献求助 收藏

Correction: The Macular Choroidal Thickness in Danish Children with Myopia After Two-Year Low-Dose Atropine and One-Year Wash-Out: A Placebo-Controlled, Randomized Clinical Trial

矫正：丹麦近视儿童接受两年低剂量阿托品治疗和一年洗脱期后黄斑脉络膜厚度的变化：一项安慰剂对照、随机临床试验

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-025-01154-7
Hansen, Niklas C; Hvid-Hansen, Anders; Bek, Toke; Møller, Flemming; Jacobsen, Nina; Kessel, Line
发表日期：2025
文献求助 收藏

Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. J. Pers. Med. 2024, 14, 175

更正：Hansen 等人，《0.01% 阿托品滴眼液和 0.1% 负荷剂量治疗丹麦儿童近视进展减缓的两年结果：一项安慰剂对照随机临床试验》，《人格医学杂志》，2024 年，14 卷，175 页。

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm15120628
Hansen, Niklas Cyril; Hvid-Hansen, Anders; Møller, Flemming; Bek, Toke; Larsen, Dorte Ancher; Jacobsen, Nina; Kessel, Line
发表日期：2025
文献求助 收藏

Efficacy of interventions for myopia control in children: A systematic review with network meta-analyses

儿童近视控制干预措施的有效性：一项系统评价和网络荟萃分析

期刊:Acta Ophthalmologica
影响因子:2.8
doi:10.1111/aos.17496
Schmidt, Diana Chabané; Hvid-Hansen, Anders; Jacobsen, Nina; Jakobsen, Trine Møldrup; Larsen, Per Michael; Lindblad, Kjersti Kristin; Møller, Flemming; Slyngborg, Annette; Subhi, Yousif; Kessel, Line
发表日期：2025
文献求助 收藏

The Macular Choroidal Thickness in Danish Children with Myopia After Two-Year Low-Dose Atropine and One-Year Wash-Out: A Placebo-Controlled, Randomized Clinical Trial

丹麦近视儿童接受两年低剂量阿托品治疗和一年洗脱期后黄斑脉络膜厚度的变化：一项安慰剂对照随机临床试验

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-024-01051-5
Hansen, Niklas C; Hvid-Hansen, Anders; Bek, Toke; Møller, Flemming; Jacobsen, Nina; Kessel, Line
发表日期：2024
文献求助 收藏

Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial

丹麦儿童使用0.01%阿托品滴眼液和0.1%负荷剂量治疗近视进展减缓的两年结果：一项安慰剂对照、随机临床试验

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14020175
Hansen, Niklas Cyril; Hvid-Hansen, Anders; Møller, Flemming; Bek, Toke; Larsen, Dorte Ancher; Jacobsen, Nina; Kessel, Line
发表日期：2024
文献求助 收藏

Reproducibility of Mesopic and Photopic Pupil Sizes in Myopic Children Using a Dedicated Pupillometer with Human-Assisted or Automated Reading

使用专用瞳孔计进行人工辅助或自动读数，评估近视儿童在中间视觉和明视觉状态下瞳孔大小的可重复性

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm13020273
Hvid-Hansen, Anders; Bækgaard, Per; Jacobsen, Nina; Hjortdal, Jesper; Møller, Flemming; Kessel, Line
Human
发表日期：2023
文献求助 收藏

Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study

欧洲儿童使用低剂量阿托品控制近视：一项随机、双盲、安慰剂对照、多中心研究的六个月结果

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm13020325
Hvid-Hansen, Anders; Jacobsen, Nina; Møller, Flemming; Bek, Toke; Ozenne, Brice; Kessel, Line
发表日期：2023
文献求助 收藏

A randomised trial of [(18)F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol

一项比较[(18)F]PSMA-1007-PET/CT与NaF-PET/CT在原发性前列腺癌分期中的随机试验：试验方案

期刊:BJUI Compass
影响因子:1.9
doi:10.1002/bco2.243
Buch-Olsen, Karen Middelbo; Poulsen, Mads Hvid; Hansen, Steinbjørn; Vilstrup, Mie Holm; Holm, Jorun; Hess, Søren; Holdgaard, Paw Christian; Zieger, Karsten Egbert Arnold; Madsen, Søren Sørensen; Gerke, Oke; Pedersen, Kasper Tholstrup; Dam, Johan Hygum; Langkjær, Niels; Østergaard, Louise Dorner; Asmussen, Jon Thor; Braad, Poul Erik; Nørgaard, Birgitte; Eiber, Matthias; Hildebrandt, Malene Grubbe
肿瘤
前列腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety

0.01%和0.1%低剂量阿托品滴眼液方案在丹麦儿童中减缓近视进展的安全性和有效性：一项随机临床试验，考察一年疗效和安全性

期刊:BMC Ophthalmology
影响因子:1.7
doi:10.1186/s12886-023-03177-9
Hansen, Niklas Cyril; Hvid-Hansen, Anders; Møller, Flemming; Bek, Toke; Larsen, Dorte Ancher; Jacobsen, Nina; Kessel, Line
发表日期：2023
文献求助 收藏